← Leaderboards
Talia Adi
University Of Pittsburgh At Pittsburgh
$146,206
Attributed
$146,206
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2023–25$50K$37.5K$25K$12.5K$0
'23
'24
'25
Funding mix
By agency
NIH$146,206 · 1
By mechanism
F31$146,206 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- David Tom Huang$5,966,166
- Peter A Friedman$14,125,747
- Carlos Cruchaga$41,433,350
- Yan Xu$24,756,156
- Stephen G. Weber$11,786,266
Others in their field
Other Rising Stars on “Afferent Neurons”
- Qin Zheng · Johns Hopkins University$2,714,830
- Joshua D. Wythe · Baylor College Of Medicine$2,697,001
- Dimitry Sayenko · Methodist Hospital Research Institute$2,544,362
- Scott Allen Norris · Washington University$2,393,905
- Zhenying Nie · Oregon Health & Science University$2,104,930
- Zheng Herbert Wu · Icahn School Of Medicine At Mount Sinai$2,052,068
Research focus
Afferent NeuronsAntagonistAttenuatedAnatomyBehaviorBehavioralBehavioral AssayCalcitoninCalcitonin Gene-Related PeptideAurasCareerCaringCellsCephalicCerebrospinal FluidChronicClassic MigraineClinically RelevantCoculture TechniquesCytokineCalcitonin-Gene Related Peptide ReceptorDrug ActionEnsureEvent
Grant awards (3)
The role of meningeal immune cells in the efficacy of CGRP-based migraine therapies$49,538
F31 · FY2025 · NS · contact PI
The role of meningeal immune cells in the efficacy of CGRP-based migraine therapies$48,974
F31 · FY2024 · NS · contact PI
The role of meningeal immune cells in the efficacy of CGRP-based migraine therapies$47,694
F31 · FY2023 · NS · contact PI